Retrospective Study
Copyright ©The Author(s) 2024.
World J Cardiol. Jan 26, 2024; 16(1): 16-26
Published online Jan 26, 2024. doi: 10.4330/wjc.v16.i1.16
Table 2 Characteristics of lesions based on the occurrence of coronary spasms during spasm provocation tests and the dose of acetylcholine

Group N
Group L
Group MH
P value
n492558
RCA/LAD27/229/1627/310.290
Atherosclerosis (%)23 (47)9 (36)28 (48)0.568
Unavoidable use of NTG4 (8)3 (12)5 (9)0.851
Coronary spasm
      Focal/diffuse8/1714/44
      Proximal/mid/distal4/15/65/35/18
iFR0.98 ± 0.040.92 ± 0.090.98 ± 0.060.104
      n15511
Pd/Pa
      Baseline0.98 ± 0.040.94 ± 0.050.96 ± 0.050.001
      Low dose of ACh0.96 ± 0.050.72 ± 0.140.90 ± 0.06< 0.001
      Pd/Pa (Low dose-baseline)−0.03 ± 0.03−0.22 ± 0.14−0.06 ± 0.05< 0.001
      Moderate-high doses of ACh0.93 ± 0.060.78 ± 0.13< 0.001
FFR1.010.81 ± 0.090.87 ± 0.090.093
      n1613